Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial
Background Acute exacerbation (AE) in idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias (IIPs) are poor prognostic events although they are usually treated with conventional therapy with corticosteroids and immunosuppressants. Previously, we demonstrated the safety and effic...
Saved in:
| Main Authors: | Yoshikazu Inoue, Satoshi Marumo, Toru Arai, Hiroshi Kida, Yoshitaka Ogata, Hiroto Matsuoka, Iwao Gohma, Suguru Yamamoto, Masahide Mori, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/7/1/e000558.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis
by: Kazunobu Tachibana, et al.
Published: (2023-01-01) -
Idiopathic Inflammatory Myopathies-Associated Interstitial Lung Disease in Adults
by: Mitsuhiro Moda, et al.
Published: (2025-01-01) -
Thrombomodulin resistance as a novel prothrombotic pathway in COVID-19
by: Ana Marco-Rico, et al.
Published: (2025-08-01) -
Association of thrombomodulin with the severity of chronic kidney disease: a cross-sectional study
by: Ming Guo, et al.
Published: (2025-05-01) -
Thrombomodulin and Lactate Dehydrogenase as Potential Predictors of Leg Ulcers in Sickle Cell Disease
by: Helen C. Okoye, et al.
Published: (2025-01-01)